AHMED NADIM 4
4 · Cullinan Oncology, Inc. · Filed Mar 27, 2023
Insider Transaction Report
Form 4
AHMED NADIM
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2023-03-23$10.51/sh−706$7,420→ 118,004 total
Footnotes (1)
- [F1]Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.